Evaluating the Association between Assisted Conception and the Severity of Preeclampsia

Table 4

Analysis of preeclamptic disease severity: assisted versus unassisted conceptions.

Variable	Assisted^†  % (𝑁=16)	Unassisted^‡  % (𝑁=424)	𝑃 value
Severe disease	100 (16)	60.9 (258)	0.0036
Systolic BP >160	56.3 (9)	78.8 (334)	0.068
Diastolic BP >105	37.5 (6)	34.7 (147)	0.97
IV BP medication	25 (4)	25.2 (107)	0.79
Proteinuria ≥2+	75 (12)	35.4 (150)	0.0031
Creatinine ≥1.0	50 (8)	18.6 (79)	0.0056
AST ≥45	62.5 (10)	20.3 (86)	0.0002
ALT ≥60	31.3 (5)	11.3 (48)	0.0441
Platelets <100	25 (4)	6.4 (27)	0.0182
IUGR <10%	50 (8)	27.4 (116)	0.09

^†Assisted pregnancies included use of clomiphene citrate, gonadotropins, IUI, IVF, ICSI, and donor egg,
^‡Women with unassisted pregnancies did not report use of clomiphene citrate, gonadotropins, IUI, IVF, ICSI, or donor egg for conception.